Julie Magno Zito

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
    J M Zito
    Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, USA
    Arch Pediatr Adolesc Med 153:1257-63. 1999
  2. ncbi Is there a connection between methylphenidate and cancer in youth?
    Julie Magno Zito
    University of Maryland, Pharmaceutical Health, 220 Arch St, Baltimore, Maryland, USA
    Pharmacoepidemiol Drug Saf 16:1273-4. 2007
  3. ncbi Regulating drugs for effectiveness and safety: a public health perspective
    Julie M Zito
    Pharmaceutical Health Services Department, University of Maryland, Baltimore, Maryland 21201, USA
    Med Care 45:911. 2007
  4. ncbi Psychotherapeutic medication prevalence in Medicaid-insured preschoolers
    Julie M Zito
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    J Child Adolesc Psychopharmacol 17:195-203. 2007
  5. ncbi Antidepressant prevalence for youths: a multi-national comparison
    Julie M Zito
    University of Maryland, Baltimore, MD 21201, USA
    Pharmacoepidemiol Drug Saf 15:793-8. 2006
  6. ncbi Anticonvulsant treatment for psychiatric and seizure indications among youths
    Julie Magno Zito
    Department of Pharmaceutical Health Services Research, University of Maryland in Baltimore, MD 21201, USA
    Psychiatr Serv 57:681-5. 2006
  7. ncbi Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths
    Julie Magno Zito
    University of Maryland, Baltimore, 515 West Lombard Street, Baltimore, Maryland 21201, USA
    Psychiatr Serv 56:157-63. 2005
  8. ncbi Psychotropic medication patterns among youth in foster care
    Julie M Zito
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
    Pediatrics 121:e157-63. 2008
  9. ncbi Psychotropic practice patterns for youth: a 10-year perspective
    Julie Magno Zito
    Department of Pharmacy Practice and Science, University of Maryland, 100 Greene St, Room 5 13, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 157:17-25. 2003
  10. ncbi Trends in the prescribing of psychotropic medications to preschoolers
    J M Zito
    School of Pharmacy, University of Maryland, Baltimore 21201, USA
    JAMA 283:1025-30. 2000

Detail Information

Publications25

  1. ncbi Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
    J M Zito
    Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, USA
    Arch Pediatr Adolesc Med 153:1257-63. 1999
    ....
  2. ncbi Is there a connection between methylphenidate and cancer in youth?
    Julie Magno Zito
    University of Maryland, Pharmaceutical Health, 220 Arch St, Baltimore, Maryland, USA
    Pharmacoepidemiol Drug Saf 16:1273-4. 2007
  3. ncbi Regulating drugs for effectiveness and safety: a public health perspective
    Julie M Zito
    Pharmaceutical Health Services Department, University of Maryland, Baltimore, Maryland 21201, USA
    Med Care 45:911. 2007
  4. ncbi Psychotherapeutic medication prevalence in Medicaid-insured preschoolers
    Julie M Zito
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    J Child Adolesc Psychopharmacol 17:195-203. 2007
    ..To update knowledge of the prevalence of the use of psychotherapeutic medications in preschoolers with Medicaid insurance as requested by the Best Pharmaceuticals for Children Act of 2002 (BPCA)...
  5. ncbi Antidepressant prevalence for youths: a multi-national comparison
    Julie M Zito
    University of Maryland, Baltimore, MD 21201, USA
    Pharmacoepidemiol Drug Saf 15:793-8. 2006
    ..To compare antidepressant prevalence data in youths across three western European countries (Denmark, Germany, and the Netherlands) with US regional data in terms of age and gender and to show proportional subclass antidepressant (ATD) use...
  6. ncbi Anticonvulsant treatment for psychiatric and seizure indications among youths
    Julie Magno Zito
    Department of Pharmaceutical Health Services Research, University of Maryland in Baltimore, MD 21201, USA
    Psychiatr Serv 57:681-5. 2006
    ..This study compared the prevalence of anticonvulsant treatment for youths with a diagnosis of a psychiatric disorder to youths with a diagnosis of a seizure disorder...
  7. ncbi Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths
    Julie Magno Zito
    University of Maryland, Baltimore, 515 West Lombard Street, Baltimore, Maryland 21201, USA
    Psychiatr Serv 56:157-63. 2005
    ..This study sought to determine the degree to which Medicaid eligibility categories modify disparities between black and white youths in the prevalence of psychotropic medication...
  8. ncbi Psychotropic medication patterns among youth in foster care
    Julie M Zito
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
    Pediatrics 121:e157-63. 2008
    ..Systematic data on patterns of medication treatment, particularly concomitant drugs, for youth in foster care are limited...
  9. ncbi Psychotropic practice patterns for youth: a 10-year perspective
    Julie Magno Zito
    Department of Pharmacy Practice and Science, University of Maryland, 100 Greene St, Room 5 13, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 157:17-25. 2003
    ..To examine changes in the full spectrum of psychotropic medication treatment for youths from 1987 to 1996...
  10. ncbi Trends in the prescribing of psychotropic medications to preschoolers
    J M Zito
    School of Pharmacy, University of Maryland, Baltimore 21201, USA
    JAMA 283:1025-30. 2000
    ..Recent reports on the use of psychotropic medications for preschool-aged children with behavioral and emotional disorders warrant further examination of trends in the type and extent of drug therapy and sociodemographic correlates...
  11. ncbi Five burning questions
    Julie Magno Zito
    School of Pharmacy, University of Maryland, Baltimore 21201, USA
    J Dev Behav Pediatr 23:S23-30. 2002
  12. ncbi Rising prevalence of antidepressants among US youths
    Julie Magno Zito
    School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Pediatrics 109:721-7. 2002
    ..To examine changes in antidepressant (ATD) prevalence and the sociodemographic and clinical correlates of ATD use among youths who are treated in community practice settings...
  13. ncbi Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths
    Daniel J Safer
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
    Psychiatr Serv 55:1049-51. 2004
    ..These administrative differences may partly explain the comparatively higher rate of psychotropic use under the SCHIP...
  14. ncbi Concomitant psychotropic medication for youths
    Daniel J Safer
    Division of Child Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Am J Psychiatry 160:438-49. 2003
    ..This study reviewed the clinical research and practice literature relating to the prevalence and patterns of concomitant psychotropic medication given to youths with emotional and behavioral disorders...
  15. ncbi Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia
    Susan dosReis
    Johns Hopkins Hospital, Division of Child and Adolescent Psychiatry, Baltimore, MD 21287 3325, USA
    Schizophr Bull 28:607-17. 2002
    ..Likewise, concurrent antiparkinsonian treatment exceeded the 1990 World Health Organization recommendations...
  16. ncbi Commentary on Dr. Walkup's guest editorial
    Julie Magno Zito
    University of Maryland, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 13:445-7; author's reply 448. 2003
  17. ncbi Pharmacoepidemiology: recent findings and challenges for child and adolescent psychopharmacology
    Julie Magno Zito
    University of Maryland, Baltimore, USA
    J Clin Psychiatry 68:966-7. 2007
  18. ncbi Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder
    Susan dosReis
    Division of Child and Adolescent Psychiatry, School of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    J Dev Behav Pediatr 24:155-62. 2003
    ..The findings highlight parental misconceptions and reservations about ADHD medication treatment that require clarification as to whether race/ethnicity, income, and social status influence their views and use of treatments...
  19. ncbi Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents
    Daniel J Safer
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21218, USA
    J Child Adolesc Psychopharmacol 16:159-69. 2006
    ..The aim of this study was to report the frequency of common treatment-emergent adverse events (AEs) from selective serotonin reuptake inhibitors (SSRIs) in children, adolescents, and adults...
  20. ncbi Effect of initial ziprasidone dose on treatment persistence in schizophrenia
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard Street, Room 262, Baltimore, MD 21201, United States
    Schizophr Res 83:277-84. 2006
    ..To determine the relationship between ziprasidone initial dose and treatment persistence among patients diagnosed with schizophrenia...
  21. ncbi Mental health services for youths in foster care and disabled youths
    S dosReis
    School of Pharmacy, University of Maryland, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am J Public Health 91:1094-9. 2001
    ..This study assessed whether mental health services for youths differ with respect to medical assistance aid category...
  22. ncbi Services and prevention: pharmacoepidemiology of antidepressant use
    J M Zito
    Department of Pharmacy Practice and Science, University of Maryland, Baltimore 21201, USA
    Biol Psychiatry 49:1121-7. 2001
    ..Finally, the implications of an expanded knowledge base for ATD treatments are discussed in regard to generating research questions on effectiveness and safety and to improve treatment consensus within a public-health perspective...
  23. ncbi Pemoline hepatotoxicity and postmarketing surveillance
    D J Safer
    Division of Child Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Am Acad Child Adolesc Psychiatry 40:622-9. 2001
    ..S. Food and Drug Administration (FDA) between 1975 and 1996 and to describe the medical community's lack of awareness of these reports...
  24. ncbi Antidepressant use in children and adolescents in Germany
    Jorg M Fegert
    Universitätsklinik für Kinder und Jugendpsychiatrie Psychotherapie, Ulm, Germany
    J Child Adolesc Psychopharmacol 16:197-206. 2006
    ..This study describes prescription patterns of antidepressants (ATD) for youths in Germany for the years 2000-2003 and includes prescription use of St. John's Wort...
  25. ncbi Adolescent stimulant use
    Daniel Safer
    CMAJ 167:15; author reply 15-6. 2002